Recital 70, Decision_act (EU) 2004/104

In forcesince 27 Nov 2002

There is agreement between the parties that [Merck employee 1] and [Aventis employee 1] were responsible for developing the modalities of the cartel. [Merck employee 1] states: "[Merck employee 3] introduced him to [Aventis employee 1]. The actual agreements with Rhône-Poulenc, though, were only developed by [Merck employee 1] together with [Aventis employee 1]"(45). Aventis states "it appears that prior to 1990 meglumine (methylglucamine) related matters have not been discussed during the meetings held at Merck's premises and which were focused on [another product] sales. However, as indicated above, the situation evolved when, at the beginning of the 1990s, a yearly meeting was held between [Aventis employee 1] and his counterpart at Merck, [Merck employee 1] to discuss meglumine-related matters"(46).